PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30142009-4	2019	Exposure to [sorafenib + vorinostat] reduced the expression of beta-catenin, ERBB1, BCL-XL and MCL-1, and the phosphorylation of AKT T308, AKT S473, GSK3 S9/21, mTORC1 and mTORC2.	Sorafenib	13-22	AKT serine/threonine kinase 1	Homo sapiens	129-132	
30142009-4	2019	Exposure to [sorafenib + vorinostat] reduced the expression of beta-catenin, ERBB1, BCL-XL and MCL-1, and the phosphorylation of AKT T308, AKT S473, GSK3 S9/21, mTORC1 and mTORC2.	Sorafenib	13-22	AKT serine/threonine kinase 1	Homo sapiens	139-142